Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Classification of laterality and mastectomy/lumpectomy for breast cancer patients for improved performance of deep learning auto segmentation.
Vivancos Bargalló H, Stick LB, Korreman SS, Kronborg C, Nielsen MM, Borgen AC, Offersen BV, Nørrevang O, Kallehauge JF. Vivancos Bargalló H, et al. Among authors: offersen bv. Acta Oncol. 2023 Nov;62(11):1546-1550. doi: 10.1080/0284186X.2023.2245965. Epub 2023 Aug 16. Acta Oncol. 2023. PMID: 37584197 No abstract available.
Haste makes waste: are the data regarding TARGIT-A IORT ready for prime time?
Kaidar-Person O, Poortmans P, Klimberg S, Haviland J, Offersen B, Audisio R, Yarnold J. Kaidar-Person O, et al. Breast Cancer Res Treat. 2014 Aug;147(1):221-2. doi: 10.1007/s10549-014-3032-5. Epub 2014 Jul 22. Breast Cancer Res Treat. 2014. PMID: 25048466 No abstract available.
Inter-observer variation in delineation of the heart and left anterior descending coronary artery in radiotherapy for breast cancer: a multi-centre study from Denmark and the UK.
Lorenzen EL, Taylor CW, Maraldo M, Nielsen MH, Offersen BV, Andersen MR, O'Dwyer D, Larsen L, Duxbury S, Jhitta B, Darby SC, Ewertz M, Brink C. Lorenzen EL, et al. Among authors: offersen bv. Radiother Oncol. 2013 Aug;108(2):254-8. doi: 10.1016/j.radonc.2013.06.025. Epub 2013 Jul 25. Radiother Oncol. 2013. PMID: 23891098
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).
Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F, A'Hern R, Bliss J, Bogaerts J, Bonnefoi H, Brain E, Cardoso MJ, Chibaudel B, Coleman R, Cufer T, Dal Lago L, Dalenc F, De Azambuja E, Debled M, Delaloge S, Filleron T, Gligorov J, Gutowski M, Jacot W, Kirkove C, MacGrogan G, Michiels S, Negreiros I, Offersen BV, Penault Llorca F, Pruneri G, Roche H, Russell NS, Schmitt F, Servent V, Thürlimann B, Untch M, van der Hage JA, van Tienhoven G, Wildiers H, Yarnold J, Bonnetain F, Mathoulin-Pélissier S, Bellera C, Dabakuyo-Yonli TS. Gourgou-Bourgade S, et al. Among authors: offersen bv. Ann Oncol. 2015 Dec;26(12):2505-6. doi: 10.1093/annonc/mdv478. Epub 2015 Oct 13. Ann Oncol. 2015. PMID: 26467471 Free article. No abstract available.
In Regard to Vaidya et al.
Wazer DE, Hepel JT, Riker AI, Harness JK, Chung C, Khan AJ, Offersen BV, Poortmans P, Taghian A. Wazer DE, et al. Among authors: offersen bv. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):952-953. doi: 10.1016/j.ijrobp.2015.05.032. Epub 2015 Jul 14. Int J Radiat Oncol Biol Phys. 2015. PMID: 26194662 No abstract available.
141 results